RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

TFA Therapeutics, Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026

$9.18+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

TFA Therapeutics, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	1.25	1.25	0.88	0.05	0.88
Cost of Revenue	0.48	0.35	0.12	0.01	1.06
Gross Profit	0.76	0.91	0.77	0.04	-0.18
Research & Development	–	–	–	0.12	0.03
General & Administrative	–	–	0.54	0.34	0.09
Operating Expenses	0.90	1.09	0.54	0.45	0.12
Operating Income	-0.14	-0.18	0.23	-0.42	-0.12
Interest Expense	–	–	0.03	0.07	0.01
Interest & Investment Income	–	–	0.00	0.00	0.00
Other Non-Operating Income	-0.01	-0.01	-0.04	0.00	0.00
Asset Impairment Charges	–	–	–	0.00	–
Gain (Loss) on Sale of Assets	–	0.00	2.44	–	–
Pretax Income	-0.15	-0.19	0.19	-0.42	-0.12
Income Tax Expense	–	0.03	0.02	0.00	0.00
Income from Continuing Operations	-0.15	-0.23	0.17	-0.42	-0.12
Income from Discontinued Operations	–	–	0.58	-0.30	-0.37
Net Income	-0.15	-0.23	0.75	-0.72	-0.49
EPS (Basic)(per share)	0.00	0.00	0.01	-0.01	-4.91
EPS (Diluted)(per share)	0.00	0.00	0.01	-0.01	-4.91
Shares Outstanding (Basic, Weighted)(shares)	111	111	111	104	0.10
Shares Outstanding (Diluted, Weighted)(shares)	111	111	111	104	0.10
EBITDA	–	–	0.28	-0.39	0.03

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 61.1%
Operating margin: -11.3%
Net margin: -12.4%
Return on equity, FY2025: 34.0%

Financial strength

Current ratio: 0.19
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –